Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.572, 2009-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Fludarabine + cyclophosphamide effective for CLL
Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. :
Cladribine, cyclophosphamide, mitoxantrone effective for CLL
Inpharma, Vol. 1, Iss. 1553, 2006-01 ,pp. :
Infant hep B, Hib vaccines both highly cost effective
Inpharma, Vol. 1, Iss. 1504, 2005-01 ,pp. :
Trastuzumab gets the go ahead on both sides of the world
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 511, 2006-01 ,pp. :
Alemtuzumab: an effective front-line option for CLL?
Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. :